150 related articles for article (PubMed ID: 6099951)
1. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection.
Eggleston PA; Hendley JO; Gwaltney JM
Acta Otolaryngol Suppl; 1984; 413():25-35. PubMed ID: 6099951
[TBL] [Abstract][Full Text] [Related]
2. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections.
Igarashi Y; Skoner DP; Doyle WJ; White MV; Fireman P; Kaliner MA
J Allergy Clin Immunol; 1993 Nov; 92(5):722-31. PubMed ID: 8227864
[TBL] [Abstract][Full Text] [Related]
3. Kinins are generated in nasal secretions during natural rhinovirus colds.
Proud D; Naclerio RM; Gwaltney JM; Hendley JO
J Infect Dis; 1990 Jan; 161(1):120-3. PubMed ID: 2295843
[TBL] [Abstract][Full Text] [Related]
4. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects.
Calhoun WJ; Dick EC; Schwartz LB; Busse WW
J Clin Invest; 1994 Dec; 94(6):2200-8. PubMed ID: 7989575
[TBL] [Abstract][Full Text] [Related]
5. Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection.
Naclerio RM; Proud D; Kagey-Sobotka A; Lichtenstein LM; Hendley JO; Gwaltney JM
Pediatr Infect Dis J; 1988 Mar; 7(3):218-22. PubMed ID: 3357721
[TBL] [Abstract][Full Text] [Related]
6. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds.
Turner RB; Weingand KW; Yeh CH; Leedy DW
Clin Infect Dis; 1998 Apr; 26(4):840-6. PubMed ID: 9564459
[TBL] [Abstract][Full Text] [Related]
7. Kinins are generated during experimental rhinovirus colds.
Naclerio RM; Proud D; Lichtenstein LM; Kagey-Sobotka A; Hendley JO; Sorrentino J; Gwaltney JM
J Infect Dis; 1988 Jan; 157(1):133-42. PubMed ID: 2447198
[TBL] [Abstract][Full Text] [Related]
8. Amplified rhinovirus colds in atopic subjects.
Bardin PG; Fraenkel DJ; Sanderson G; Dorward M; Lau LC; Johnston SL; Holgate ST
Clin Exp Allergy; 1994 May; 24(5):457-64. PubMed ID: 8087657
[TBL] [Abstract][Full Text] [Related]
9. Effects on the nasal mucosa of upper respiratory viruses (common cold).
Winther B
Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds.
Fraenkel DJ; Bardin PG; Sanderson G; Lampe F; Johnston SL; Holgate ST
Am J Respir Crit Care Med; 1994 Oct; 150(4):1130-6. PubMed ID: 7921447
[TBL] [Abstract][Full Text] [Related]
11. Histamine in nasal secretions and serum may be elevated during viral respiratory tract infections.
Smith TF; Remigio LK
Int Arch Allergy Appl Immunol; 1982; 67(4):380-3. PubMed ID: 6175587
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds.
Proud D; Gwaltney JM; Hendley JO; Dinarello CA; Gillis S; Schleimer RP
J Infect Dis; 1994 May; 169(5):1007-13. PubMed ID: 8169385
[TBL] [Abstract][Full Text] [Related]
13. Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum.
Douglas RG; Rossen RD; Butler WT; Couch RB
J Immunol; 1967 Aug; 99(2):297-303. PubMed ID: 4166403
[No Abstract] [Full Text] [Related]
14. Evaluation of an enzyme-linked immunosorbent assay that measures rhinovirus-specific antibodies in human sera and nasal secretions.
Barclay WS; Callow KA; Sergeant M; al-Nakib W
J Med Virol; 1988 Aug; 25(4):475-82. PubMed ID: 2844987
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
[TBL] [Abstract][Full Text] [Related]
16. Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial.
Abisheganaden JA; Avila PC; Kishiyama JL; Liu J; Yagi S; Schnurr D; Boushey HA
Am J Med; 2000 Apr; 108(6):453-9. PubMed ID: 10781777
[TBL] [Abstract][Full Text] [Related]
17. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air.
Togias AG; Proud D; Lichtenstein LM; Adams GK; Norman PS; Kagey-Sobotka A; Naclerio RM
Am Rev Respir Dis; 1988 Mar; 137(3):625-9. PubMed ID: 2449835
[TBL] [Abstract][Full Text] [Related]
18. An update on the pathophysiology of rhinovirus upper respiratory tract infections.
van Kempen M; Bachert C; Van Cauwenberge P
Rhinology; 1999 Sep; 37(3):97-103. PubMed ID: 10567986
[TBL] [Abstract][Full Text] [Related]
19. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.
Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U
Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995
[TBL] [Abstract][Full Text] [Related]
20. Experimental rhinovirus infection in human volunteers exposed to ozone.
Henderson FW; Dubovi EJ; Harder S; Seal E; Graham D
Am Rev Respir Dis; 1988 May; 137(5):1124-8. PubMed ID: 2461669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
